BYND Cannasoft: 3 Catalysts to Watch in 2023
January 5th, 2023
News, Top News
Most investors appreciate that stock prices reflect future expectations more than past results. After all, many “value stocks” trade at a discount despite strong existing businesses, whereas many “growth stocks” trade at a premium despite their lack of current revenue or income. As a result, the best opportunities often have numerous catalysts ahead of them.
BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) (CSE: BYND) represents a unique opportunity in the cannabis (and cannabinoid) space with its innovative EZ-G device and medical cannabis plans.
Launching the EZ-G Device
BYND Cannasoft acquired the patent-pending intellectual property for the EZ-G device earlier this year. The therapeutic device uses low concentrations of CBD oil to treat female reproductive health issues, including candida, dryness, and scars. These conditions represent multi-billion-dollar addressable markets alone.
In addition to its therapeutic potential, the company expanded the patent to include an innovative double-faceted condom design with a double pocket containing lubricant to improve sexual experiences. These additions could help target the $60+ billion sex toy market with a unique product designed to enhance pleasure.
The company anticipates completing the development of the EZ-G device in 2023, bringing it closer to commercialization. If successful, the company could see significant near-term consumer demand for the innovative device in the recreational market while it pursues FDA and other regulatory approvals in the therapeutic market.
Obtaining a Cannabis License
BYND Cannasoft recently secured initial approval to trade medical cannabis without direct contact with the substance from the Israel Ministry of Health. The approval comes as part of the process to obtain a full license, enabling the company to trade in medical cannabis products through an agreement with a licensed cannabis grower.
In October 2022, the company secured an agreement with Globus Pharma Ltd. to cultivate, produce, and distribute medical cannabis products. The move enables it to provide products and strains that it co-develops with the licensed cannabis grower to target various niche segments of the medical cannabis industry.
The company anticipates completing the procedures for obtaining a license to trade in medical cannabis in the new year. If successful, the company could be well-positioned to generate significant profits from production and distribution to Israeli pharmacies. The company also hopes to expand distribution into the U.K. and Germany.
Scaling the Cannabis CRM
BYND Cannasoft’s legacy customer relationship management (CRM) business continues to drive revenue. But, building on its 20 years of experience, the company recently began developing a new CRM platform specifically targeting the medical cannabis industry. The goal is to make the industry more organized, accessible, and price transparent.
In October 2022, the company signed an agreement with the Weizmann Institute of Science to develop a beta version of its cannabis CRM. The product will help manage farms and greenhouses with varied crops. And in the new year, the company will continue advancing the product toward an eventual launch into the multi-billion dollar cannabis CRM market.
BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) (CSE: BYND) has three significant catalysts that could help drive the stock price in 2023. Investors may want to keep an eye on the stock as it continues to advance its EZ-G and Cannabis CRM products, as well as work toward a medical cannabis distribution license.
For more information, visit the company’s website or complete the form below to download their investor presentation.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.